On Open-Label Study in Participants With Systemic Lupus Erythematosus

Clinical trial NCT01488708 · TERMINATED

Trial details

NCT number: NCT01488708
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Connective Tissue Disease Autoimmune Disease

Start date: 2012-01-01
Primary completion: 2015-10-01
Enrollment: 1518

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.